Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours

被引:57
作者
Martinsson, T [1 ]
Sjöberg, RM
Hallstensson, K
Nordling, M
Hedborg, F
Kogner, P
机构
[1] Gothenburg Univ, East Hosp, Dept Clin Genet, S-41685 Gothenburg, Sweden
[2] Univ Uppsala, Dept Pathol, S-75105 Uppsala, Sweden
[3] Karolinska Hosp, Karolinska Inst, Childhood Canc Res Unit, S-10401 Stockholm, Sweden
关键词
neuroblastoma; tumour suppressor gene; CDC2L1; deletion; 1p36; LOH;
D O I
10.1016/S0959-8049(97)00278-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analysed DNA from 68 neuroblastoma tumours for loss of heterozygosity (LOH) on the distal chromosome 1p (1p-LOH) using PCR-based DNA polymorphisms. Fifteen tumours (22%) displayed 1p-LOH. The shortest region of overlap (SRO) for the deletions was defined proximally by marker D1S244 and distally by marker D1S80. The CDC2L1 locus, located on chromosome 1p36, has been put forward as a neuroblastoma tumour suppressor. We analysed coding regions of the CDC2L1 gene in a subset of aggressive neuroblastoma tumours with known allelic loss for different 1p-markers. Single-stranded conformation polymorphism, heteroduplex and sequencing analysis of tumour DNA did not reveal any significant changes in the coding region. Using a DNA sequence polymorphism, we showed, in a primary tumour with an interstitial allelic deletion, that this tumour had both alleles of the CDC2L1 locus retained in the tumour. Thus, we showed that the neuroblastoma tumour suppressor critical region on 1p in our material is defined by loci D1S244 and D1S80 and that the CDC2L1 locus is distal to the critical region. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1997 / 2001
页数:5
相关论文
共 29 条
[1]  
BIEGEL JA, 1993, AM J HUM GENET, V52, P176
[2]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[3]  
BRODEUR GM, 1981, CANCER RES, V41, P4678
[4]  
BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO
[5]  
2-1
[6]   INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].
BRODEUR, GM ;
SEEGER, RC ;
BARRETT, A ;
BERTHOLD, F ;
CASTLEBERRY, RP ;
DANGIO, G ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
FREEMAN, AI ;
HAASE, G ;
HARTMANN, O ;
HAYES, FA ;
HELSON, L ;
KEMSHEAD, J ;
LAMPERT, F ;
NINANE, J ;
OHKAWA, H ;
PHILIP, T ;
PINKERTON, CR ;
PRITCHARD, J ;
SAWADA, T ;
SIEGEL, S ;
SMITH, EI ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881
[7]  
BUDOWLE B, 1991, AM J HUM GENET, V48, P137
[8]   INTEGRATED HUMAN GENOME-WIDE MAPS CONSTRUCTED USING THE CEPH REFERENCE PANEL [J].
BUETOW, KH ;
WEBER, JL ;
LUDWIGSEN, S ;
SCHERPBIERHEDDEMA, T ;
DUYK, GM ;
SHEFFIELD, VC ;
WANG, ZY ;
MURRAY, JC .
NATURE GENETICS, 1994, 6 (04) :391-393
[9]   EVIDENCE FOR 2 TUMOR-SUPPRESSOR LOCI ON CHROMOSOMAL BANDS-1P35-36 INVOLVED IN NEUROBLASTOMA - ONE PROBABLY IMPRINTED, ANOTHER ASSOCIATED WITH N-MYC AMPLIFICATION [J].
CARON, H ;
PETER, M ;
VANSLUIS, P ;
SPELEMAN, F ;
DEKRAKER, J ;
LAUREYS, G ;
MICHON, J ;
BRUGIERES, L ;
VOUTE, PA ;
WESTERVELD, A ;
SLATER, R ;
DELATTRE, O ;
VERSTEEG, R .
HUMAN MOLECULAR GENETICS, 1995, 4 (04) :535-539
[10]   ALLELIC LOSS OF CHROMOSOME-1P36 IN NEUROBLASTOMA IS OF PREFERENTIAL MATERNAL ORIGIN AND CORRELATES WITH N-MYC AMPLIFICATION [J].
CARON, H ;
VANSLUIS, P ;
VANHOEVE, M ;
DEKRAKER, J ;
BRAS, J ;
SLATER, R ;
MANNENS, M ;
VOUTE, PA ;
WESTERVELD, A ;
VERSTEEG, R .
NATURE GENETICS, 1993, 4 (02) :187-190